Answers are grounded in this paper and cite their sources.
Findings demonstrate metabolic reprogramming and reduced transcription of nutrient transporters in CD4+ T cells from CARD11 patients, suggesting crucial roles in T cell function.
Description Upon activation, CD4+ T cells upregulate multiple nutrient transporters to accommodate cell growth, proliferation, differentiation, and effector function. Nonetheless, molecular pathways that link TCR-dependent signaling to metabolic reprogramming in human T cells remain elusive. Here, we demonstrate a critical role for the scaffold protein CARD11 and associated components in the CBM complex are required in the activation-induced expression of key nutrient transporters in human CD4+ effector T cells, including the glutamine transporter ASCT2 (Slc1a5) and glucose transporter GLUT1 (Slc2a1). Attenuated CBM function coincided with diminished Slc1a5 transcription, while siRNA-mediated knockdown of CBM components markedly reduced TCR/CD28-dependent induction of both receptors, concomitant with impaired glutamine-dependent mTORC1 activation. Inhibiting CBM-dependent pathways such as the MALT1 protease, c-Jun N-terminal kinase (JNK), and mTORC1 decreased TCR/CD28-induced transporter expression over time. The defective expression of ASCT2 and GLUT1 transporters and impaired mTORC1 activation were also detected in CD4+ effector T cells from severe atopic patients harboring dominant-negative (DN) CARD11 mutations. Thus, our findings suggest that the CBM complex is critical for activation-induced nutrient uptake and metabolic calibration in human CD4+ T cells, yielding new insights into the aberrant T cell differentiation and Th2-driven pathogenesis observed in CARD11 DN patients.
No takes yet. Share an insight, caveat, or question.
Ruchinskas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: